bioRxivSystems BiologyPreprint
Modulation of dysbiotic vaginal complications by cervical mucus revealed in linked human vagina and cervix chips
Ola GutzeitiD, Aakanksha GulatiiD, Zohreh IzadifariD, Anna StejskalováiD, Hassan Rhbiny, Justin CottoniD, Bogdan BudnikiD, Sanjid ShahriariD, Girija GoyaliD, Abidemi JunaidiD, Donald E. IngberiD
Abstract
BackgroundThe cervicovaginal mucus that coats the upper surface of the vaginal epithelium is thought to serve as a selective barrier that helps to clear pathogens, however, its role in modulating the physiology and pathophysiology of the human vagina is poorly understood. Bacterial vaginosis (BV), a common disease of the female reproductive tract that increases susceptibility to sexually transmitted infections, pelvic inflammatory disease, infertility, preterm birth, and both maternal and neonatal infections is characterized by the presence of a wide array of strict and facultative anaerobes, often including Gardnerella vaginalis. ObjectiveTo assess the role of cervical mucus in preventing dysbiosis-associated complications and preserving vaginal health. Study DesignTo better understand the role of cervicovaginal mucus in vaginal health, we used human organ-on-a-chip (Organ Chip) microfluidic culture technology to analyze the effects of cervical mucus produced in a human Cervix Chip when transferred to a human Vagina Chip BV model. Both chips are lined by primary human organ-specific (cervical or vaginal) epithelium interfaced with organ-specific stromal fibroblasts. ResultsOur data show that mucus-containing effluents from Cervix Chips protect Vagina Chips from inflammation and epithelial cell injury caused by co-culture with dysbiotic microbiome containing G. vaginalis. Proteomic analysis of proteins produced by the Vagina Chip following treatment with the Cervix Chip mucus also revealed a collection of differentially abundant proteins that may contribute to the vaginal response to dysbiotic microbiome, which could represent potential diagnostic biomarkers or therapeutic targets for management of BV. ConclusionsThis study highlights the importance of cervical mucus in control of human vaginal physiology and pathophysiology, and demonstrates the potential value of Organ Chip technology for studies focused on health and diseases of the female reproductive tract.
- organism: human
- assay: proteomics
- research focus: cell-cell communication
- research focus: differential expression
- research focus: database / resource
- approach: experimental assay
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Vaginal microbiome-host interactions modeled in a human vagina-on-a-chip
G. Mahajan, E. Doherty, … D. E. Ingber·bioRxiv·Mar 20, 2022
- Vaginal bacteria-derived extracellular vesicles diffuse through human cervicovaginal mucus to enable bacterial signaling to upper female reproductive tract tissues
Darby Steinman, Alyssa Petersen, … Hannah C. Zierden·bioRxiv·Apr 28, 2025
- Mucus production, host-microbiome interactions, hormone sensitivity, and innate immune responses modeled in human cervix chips
Z. Izadifar, J. Cotton, … D. E. Ingber·bioRxiv·Feb 22, 2023
- Synergistic therapeutic effects of endolysin BNT331 and a Lactobacillus crispatus consortium in a human vagina chip model of bacterial vaginosis
Aakanksha Gulati, Alicia C. Jorgenson, … Donald E. Ingber·bioRxiv·Nov 5, 2025
- Microdroplet-enabled high-throughput cultivation of vaginal bacteria using cervicovaginal fluids
C. M. Jackman, J. Y. Tan, X. N. Lin·bioRxiv·Sep 26, 2023
- Multiomic analysis reveals that polyamines alter G. vaginalis-induced cervicovaginal epithelial cell dysfunction
Lauren Anton, Olha Kholod, … Kristin D. Gerson·bioRxiv·Nov 20, 2025